Aspen Pharmacare Holdings (JSE:APN) FCF Yield %: 4.21 (As of Jul. 01, 2026) — 44% Above Median


JSE:APN Aspen Pharmacare Holdings Ltd JSE:APN
73 GF Score
Price R156.88
GF Value R178.12
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Aspen Pharmacare Holdings FCF Yield %?

Aspen Pharmacare Holdings JSE:APN +0.60% 73 FCF Yield % is 4.21 as of Jul. 01, 2026, which is 44% above its 10-year median of 2.92. GuruFocus rates JSE:APN with a GF Score™ of 73/100 and a GF Value™ of R178.12 (Modestly Undervalued). The stock has 10 warning signs investors should review. Among 1,003 Drug Manufacturers companies, Aspen Pharmacare Holdings ranks better than 70.49% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Aspen Pharmacare Holdings's Trailing 12-Month Free Cash Flow is R2,934 Mil, and Market Cap is R69,658 Mil. Therefore, Aspen Pharmacare Holdings's FCF Yield % for today is 4.21%.

The historical rank and industry rank for Aspen Pharmacare Holdings's FCF Yield % or its related term are showing as below:

JSE:APN' s FCF Yield % Range Over the Past 10 Years
Min: -2.91   Med: 2.92   Max: 11.56
Current: 4.21


During the past 13 years, the highest FCF Yield % of Aspen Pharmacare Holdings was 11.56%. The lowest was -2.91%. And the median was 2.92%.

JSE:APN's FCF Yield % is ranked better than
70.49% of 1003 companies
in the Drug Manufacturers industry
Industry Median: 0.67 vs JSE:APN: 4.21

Aspen Pharmacare Holdings's FCF Margin % for the quarter that ended in Dec. 2025 was 11.58%.


Aspen Pharmacare Holdings FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Aspen Pharmacare Holdings FCF Yield % Related Terms


Aspen Pharmacare Holdings FCF Yield % Historical Data

* Premium members only.

The historical data trend for Aspen Pharmacare Holdings's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aspen Pharmacare Holdings FCF Yield % Chart

Aspen Pharmacare Holdings Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.60 4.33 2.87 0.67 0.20

Aspen Pharmacare Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.88 2.10 -2.33 3.61 7.62

JSE:APN vs ZTS, UTHR, VTRS: FCF Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Aspen Pharmacare Holdings's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aspen Pharmacare Holdings FCF Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aspen Pharmacare Holdings's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Aspen Pharmacare Holdings's FCF Yield % falls into.


JSE:APN
73GF Score
Aspen Pharmacare Holdings Ltd JSE:APN
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aspen Pharmacare Holdings FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Aspen Pharmacare Holdings's FCF Yield % for the fiscal year that ended in Jun. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=104 / 53056.30827
=0.20%

Aspen Pharmacare Holdings's annualized FCF Yield % for the quarter that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=1977 * 2 / 51857.44617
=7.62%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of 4.21 mean?
Aspen Pharmacare Holdings (JSE:APN) has a FCF Yield % of 4.21 as of Jul. 01, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Aspen Pharmacare Holdings and its competitors. This is 44% above median its historical median of 2.92. According to the industry distribution chart, Aspen Pharmacare Holdings ranks #296 out of 1003 companies in the Drug Manufacturers industry, placing it in the top 29.5%.
Is Aspen Pharmacare Holdings' FCF Yield % too high?
Aspen Pharmacare Holdings' current FCF Yield % of 4.21 is 44% above median its 10-year median of 2.92. The Drug Manufacturers industry median FCF Yield % is 0.67. Aspen Pharmacare Holdings' value of 4.21 is 528.4% above this industry median. Based on the distribution chart, Aspen Pharmacare Holdings ranks #296 out of 1003 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Aspen Pharmacare Holdings has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aspen Pharmacare Holdings' FCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Aspen Pharmacare Holdings ranks #296 out of 1003 companies for FCF Yield %. This puts Aspen Pharmacare Holdings in the upper half of its industry. The industry median FCF Yield % is 0.67. Aspen Pharmacare Holdings' value of 4.21 is 528.4% above this benchmark. While the company's 10-year median is 2.92 vs. the industry median of 0.67, Aspen Pharmacare Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.67, based on 1,003 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aspen Pharmacare Holdings's current FCF Yield % of 4.21 is 528.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Aspen Pharmacare Holdings and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aspen Pharmacare Holdings's current FCF Yield % is 4.21, which is 44% above median its own 10-year median of 2.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aspen Pharmacare Holdings stock overvalued right now?
Based on GuruFocus' analysis, Aspen Pharmacare Holdings (JSE:APN) is currently considered Modestly Undervalued. The stock's GF Value™ is R178.12, compared to a current price of R156.88 — trading 11.9% below its estimated fair value. The current FCF Yield % is 4.21, which is 44% above median its 10-year median of 2.92 and 528.4% above the Drug Manufacturers industry median of 0.67. Aspen Pharmacare Holdings' overall GF Score™ is 73/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Aspen Pharmacare Holdings (JSE:APN), the current FCF Yield % is 4.21 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aspen Pharmacare Holdings (JSE:APN) Overvalued in 2026?

Based on GuruFocus' analysis, Aspen Pharmacare Holdings stock appears to be undervalued. The current stock price of R156.88 is trading 11.9% below its estimated GF Value™ of R178.12. GuruFocus considers Aspen Pharmacare Holdings to be Modestly Undervalued.

Key valuation signals for JSE:APN:

  • FCF Yield %: 4.21 (44% above median its 10-year median of 2.92)
  • GF Value™: R178.12 vs. price of R156.88 (11.9% below fair value)
  • GF Score™: 73/100 with 10 warning signs
  • Industry Position: 528.4% above the Drug Manufacturers median (#296 of 1003)

No single metric tells the full story. See the JSE:APN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Aspen Pharmacare Holdings Business Description

Address Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF
Aspen Pharmacare Holdings Ltd is a multinational pharmaceutical company. The group focuses on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets. The business segments of the group are split between the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals business segments are: Injectables, Over-the-counter, and Prescription. The Manufacturing business segments are: Active Pharmaceutical Ingredients, Finished Dose Form, and Heparin. Its geographic regions are Africa Middle East, Europe CIS, Australasia, Asia, and America.
73GF Score

Get the complete analysis for JSE:APN

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R156.88
Price
R178.12
GF Value